{"instruction": "Interpret liver function profile", "input": "Male, 28 years\nALT 18 U/L, AST 20 U/L, ALP 90 U/L, GGT 24 U/L, Total bilirubin 0.7 mg/dL (Direct 0.2), Albumin 4.5 g/dL, Total protein 7.2 g/dL", "output": "Interpretation: Liver enzymes and proteins are within normal limits.\nClinical significance: No biochemical evidence of liver inflammation, cholestasis, or synthetic dysfunction.\nFuture risks: Low current risk of liver disease if other risk factors (alcohol, obesity, viral hepatitis) are controlled.\nLifestyle & follow-up: Maintain a balanced diet, avoid excessive alcohol and unnecessary medications, and repeat LFTs as part of routine checkups."}
{"instruction": "Interpret liver function profile", "input": "Female, 35 years, BMI 32\nALT 56 U/L, AST 49 U/L, ALP 105 U/L, GGT 38 U/L, Total bilirubin 0.8 mg/dL (Direct 0.3), Albumin 4.1 g/dL, Total protein 7.0 g/dL", "output": "Interpretation: Mild elevation of ALT and AST with otherwise preserved liver function.\nClinical significance: Pattern suggests mild hepatocellular injury, commonly seen in fatty liver disease or early metabolic liver injury.\nFuture risks: Risk of progression to non-alcoholic steatohepatitis (NASH), fibrosis, and long-term cirrhosis if metabolic risk factors are not addressed.\nLifestyle & follow-up: Aim for gradual weight loss, regular exercise, control of diabetes and cholesterol, avoid alcohol, and repeat LFTs and ultrasound in 3–6 months."}
{"instruction": "Interpret liver function profile", "input": "Male, 45 years, regular alcohol use\nALT 42 U/L, AST 88 U/L, ALP 120 U/L, GGT 210 U/L, Total bilirubin 1.1 mg/dL (Direct 0.4), Albumin 4.0 g/dL, Total protein 7.4 g/dL", "output": "Interpretation: AST is higher than ALT with markedly elevated GGT, suggesting alcohol-related liver injury.\nClinical significance: This pattern is typical of alcoholic liver disease or alcohol-induced hepatocellular stress.\nFuture risks: Ongoing alcohol use may lead to alcoholic hepatitis, cirrhosis, portal hypertension, and liver failure.\nLifestyle & follow-up: Strongly reduce and ideally stop alcohol completely, seek support for de-addiction if needed, maintain a nutrient-rich diet, and follow up with a liver specialist for monitoring and possible imaging."}
{"instruction": "Interpret liver function profile", "input": "Female, 52 years\nALT 19 U/L, AST 22 U/L, ALP 275 U/L, GGT 160 U/L, Total bilirubin 2.3 mg/dL (Direct 1.4), Albumin 3.9 g/dL, Total protein 7.5 g/dL", "output": "Interpretation: Predominantly cholestatic pattern with elevated ALP, GGT, and conjugated hyperbilirubinemia.\nClinical significance: Suggestive of bile duct obstruction or cholestatic disease such as gallstones, biliary stricture, or primary biliary cholangitis.\nFuture risks: Persistent obstruction can cause ascending cholangitis, secondary biliary cirrhosis, and fat-soluble vitamin deficiencies.\nLifestyle & follow-up: Seek prompt evaluation (ultrasound/CT/MRCP), avoid hepatotoxic drugs, maintain hydration, and follow a low-fat diet until the cause is clarified by a specialist."}
{"instruction": "Interpret liver function profile", "input": "Male, 60 years, known hepatitis B\nALT 132 U/L, AST 118 U/L, ALP 130 U/L, GGT 70 U/L, Total bilirubin 1.8 mg/dL (Direct 0.9), Albumin 3.5 g/dL, Total protein 7.8 g/dL", "output": "Interpretation: Moderate hepatocellular enzyme elevation with mild hyperbilirubinemia and slightly reduced albumin.\nClinical significance: Indicates active liver inflammation likely related to chronic hepatitis B flare or progression.\nFuture risks: Risk of developing fibrosis, cirrhosis, hepatocellular carcinoma, and portal hypertension if not adequately treated.\nLifestyle & follow-up: Strictly avoid alcohol, ensure antiviral treatment is optimized, vaccinate close contacts, and follow closely with a hepatologist including periodic imaging and viral load monitoring."}
{"instruction": "Interpret liver function profile", "input": "Female, 24 years, asymptomatic\nALT 15 U/L, AST 16 U/L, ALP 82 U/L, GGT 20 U/L, Total bilirubin 0.5 mg/dL (Direct 0.1), Albumin 4.6 g/dL, Total protein 7.6 g/dL", "output": "Interpretation: Completely normal liver function tests.\nClinical significance: No evidence of liver damage, cholestasis, or synthetic dysfunction.\nFuture risks: Very low current risk of liver disease in the absence of other comorbidities.\nLifestyle & follow-up: Maintain healthy body weight, avoid excessive alcohol, use medications only as prescribed, and repeat LFTs only as part of routine health evaluations."}
{"instruction": "Interpret liver function profile", "input": "Male, 38 years, metabolic syndrome\nALT 84 U/L, AST 62 U/L, ALP 115 U/L, GGT 90 U/L, Total bilirubin 0.9 mg/dL (Direct 0.3), Albumin 4.2 g/dL, Total protein 7.3 g/dL", "output": "Interpretation: Elevated transaminases with mildly raised GGT, consistent with hepatocellular pattern.\nClinical significance: Highly suggestive of non-alcoholic fatty liver disease related to metabolic syndrome.\nFuture risks: Progression to NASH, fibrosis, cirrhosis, and increased cardiovascular risk if metabolic factors remain uncontrolled.\nLifestyle & follow-up: Implement weight loss through diet and exercise, control blood pressure, diabetes, and lipids, minimize alcohol, and repeat LFTs and liver ultrasound in 3–6 months."}
{"instruction": "Interpret liver function profile", "input": "Female, 30 years, late pregnancy\nALT 22 U/L, AST 24 U/L, ALP 290 U/L, GGT 30 U/L, Total bilirubin 0.6 mg/dL (Direct 0.2), Albumin 3.3 g/dL, Total protein 6.8 g/dL", "output": "Interpretation: ALP is elevated with mildly low albumin in late pregnancy; other liver enzymes are normal.\nClinical significance: ALP elevation is expected in pregnancy due to placental isoenzyme; mild albumin reduction is also physiologic.\nFuture risks: No major liver-specific risk if blood pressure and other pregnancy parameters are normal.\nLifestyle & follow-up: Continue routine antenatal care, balanced nutrition, and follow obstetrician guidance; repeat LFTs only if symptoms like itching, jaundice, or high blood pressure develop."}
{"instruction": "Interpret liver function profile", "input": "Male, 55 years, long-standing diabetes\nALT 38 U/L, AST 41 U/L, ALP 135 U/L, GGT 65 U/L, Total bilirubin 1.0 mg/dL (Direct 0.4), Albumin 3.8 g/dL, Total protein 7.1 g/dL", "output": "Interpretation: Mild mixed hepatocellular and cholestatic pattern.\nClinical significance: Could reflect fatty liver due to diabetes, medication-related enzyme elevation, or early biliary disease.\nFuture risks: Over time, increased risk of NAFLD progression, gallstone disease, and cardiovascular complications.\nLifestyle & follow-up: Optimize diabetes control, review medications for hepatotoxicity, aim for weight loss and exercise, and consider liver ultrasound if not done recently."}
{"instruction": "Interpret liver function profile", "input": "Female, 48 years, autoimmune disease history\nALT 72 U/L, AST 70 U/L, ALP 210 U/L, GGT 95 U/L, Total bilirubin 1.5 mg/dL (Direct 0.9), Albumin 3.6 g/dL, Total protein 8.6 g/dL", "output": "Interpretation: Mixed hepatocellular and cholestatic elevation with high total protein.\nClinical significance: This profile may suggest autoimmune liver disease such as autoimmune hepatitis or primary biliary cholangitis.\nFuture risks: Progression to chronic hepatitis, cirrhosis, portal hypertension, and need for long-term immunosuppression if untreated.\nLifestyle & follow-up: Avoid alcohol and hepatotoxic drugs, see a hepatologist promptly for autoimmune workup (ANA, SMA, AMA), and follow treatment and monitoring plans closely."}
{"instruction": "Interpret liver function profile", "input": "Male, 40 years\nALT 16 U/L, AST 18 U/L, ALP 88 U/L, GGT 22 U/L, Total bilirubin 1.4 mg/dL (Direct 0.2), Albumin 4.4 g/dL, Total protein 7.5 g/dL", "output": "Interpretation: Enzymes are normal, with mildly elevated unconjugated bilirubin.\nClinical significance: Pattern suggests benign unconjugated hyperbilirubinemia, such as Gilbert syndrome, especially if stable over time.\nFuture risks: Generally benign course, no progression to liver disease.\nLifestyle & follow-up: Ensure adequate hydration, avoid fasting and unnecessary drugs, and monitor only if symptoms like significant jaundice or dark urine develop."}
{"instruction": "Interpret liver function profile", "input": "Female, 62 years\nALT 25 U/L, AST 28 U/L, ALP 310 U/L, GGT 40 U/L, Total bilirubin 0.9 mg/dL (Direct 0.3), Albumin 3.9 g/dL, Total protein 7.2 g/dL", "output": "Interpretation: Isolated ALP elevation with normal bilirubin and near-normal GGT.\nClinical significance: ALP may be of bone or liver origin; in older adults it can reflect bone disease (e.g., osteoporosis, Paget) or subclinical cholestasis.\nFuture risks: Depending on cause, possible bone fragility or biliary disease.\nLifestyle & follow-up: Check ALP isoenzymes or bone markers, consider imaging if cholestasis suspected, ensure adequate calcium/vitamin D intake, and follow specialist advice."}
{"instruction": "Interpret liver function profile", "input": "Male, 70 years, chronic liver disease\nALT 32 U/L, AST 46 U/L, ALP 140 U/L, GGT 75 U/L, Total bilirubin 2.6 mg/dL (Direct 1.8), Albumin 2.9 g/dL, Total protein 6.4 g/dL", "output": "Interpretation: Chronic liver dysfunction with hyperbilirubinemia and low albumin.\nClinical significance: Suggestive of decompensated chronic liver disease or cirrhosis with impaired synthetic function.\nFuture risks: Ascites, variceal bleeding, hepatic encephalopathy, and high risk of hospitalization.\nLifestyle & follow-up: Strictly avoid alcohol and hepatotoxins, follow low-salt diet, adhere to prescribed medications (e.g., diuretics, beta-blockers), and remain under regular hepatology supervision with periodic imaging and endoscopy."}
{"instruction": "Interpret liver function profile", "input": "Female, 19 years, viral prodrome\nALT 248 U/L, AST 220 U/L, ALP 130 U/L, GGT 55 U/L, Total bilirubin 3.4 mg/dL (Direct 2.1), Albumin 3.8 g/dL, Total protein 7.0 g/dL", "output": "Interpretation: Acute hepatocellular injury with significant enzyme elevation and jaundice.\nClinical significance: Strongly suggestive of acute viral hepatitis or drug-induced liver injury.\nFuture risks: Risk of acute liver failure is low but present if INR rises, albumin drops, or encephalopathy appears.\nLifestyle & follow-up: Immediate evaluation by a physician, stop any non-essential medications, avoid alcohol and herbal remedies, maintain hydration, and monitor LFTs and coagulation closely."}
{"instruction": "Interpret liver function profile", "input": "Male, 50 years, obese\nALT 61 U/L, AST 54 U/L, ALP 115 U/L, GGT 80 U/L, Total bilirubin 0.9 mg/dL (Direct 0.3), Albumin 4.0 g/dL, Total protein 7.3 g/dL", "output": "Interpretation: Mild hepatocellular enzyme elevation, most consistent with fatty liver.\nClinical significance: Likely non-alcoholic fatty liver disease due to obesity and metabolic risk.\nFuture risks: Increased risk of NASH, hepatic fibrosis, cirrhosis, and cardiovascular disease.\nLifestyle & follow-up: Target 7–10% weight loss, daily physical activity, limit sugar and refined carbs, avoid alcohol, and repeat LFTs and ultrasound periodically."}
{"instruction": "Interpret liver function profile", "input": "Female, 42 years, on long-term anticonvulsants\nALT 40 U/L, AST 39 U/L, ALP 180 U/L, GGT 130 U/L, Total bilirubin 0.8 mg/dL (Direct 0.3), Albumin 4.1 g/dL, Total protein 7.6 g/dL", "output": "Interpretation: Mixed enzyme elevation with high GGT in a patient on chronic medication.\nClinical significance: Could reflect drug-induced liver enzyme elevation, predominantly cholestatic.\nFuture risks: Chronic drug-induced liver injury, cholestasis, and, rarely, progressive fibrosis.\nLifestyle & follow-up: Discuss medication alternatives with the treating neurologist, avoid alcohol, monitor LFTs regularly, and consider imaging if enzymes remain elevated."}
{"instruction": "Interpret liver function profile", "input": "Male, 33 years, heavy alcohol intake\nALT 72 U/L, AST 155 U/L, ALP 150 U/L, GGT 260 U/L, Total bilirubin 2.1 mg/dL (Direct 1.3), Albumin 3.6 g/dL, Total protein 7.1 g/dL", "output": "Interpretation: Marked AST predominance with high GGT and hyperbilirubinemia, typical of alcoholic hepatitis.\nClinical significance: Indicates significant alcohol-related liver inflammation and cholestasis.\nFuture risks: High risk of progression to cirrhosis, portal hypertension, and liver failure if alcohol use continues.\nLifestyle & follow-up: Urgent need to stop alcohol with medical and psychological support, optimize nutrition, and be closely monitored by a hepatologist, including possible hospitalization for severe cases."}
{"instruction": "Interpret liver function profile", "input": "Female, 27 years, vegetarian\nALT 12 U/L, AST 14 U/L, ALP 96 U/L, GGT 18 U/L, Total bilirubin 0.4 mg/dL (Direct 0.1), Albumin 4.3 g/dL, Total protein 7.0 g/dL", "output": "Interpretation: Liver function tests are entirely normal.\nClinical significance: No evidence of liver disease.\nFuture risks: Minimal risk when lifestyle remains healthy.\nLifestyle & follow-up: Continue balanced vegetarian diet with adequate protein, avoid unnecessary medications and alcohol, and repeat LFTs only as routine."}
{"instruction": "Interpret liver function profile", "input": "Male, 65 years, chronic hepatitis C\nALT 52 U/L, AST 65 U/L, ALP 135 U/L, GGT 88 U/L, Total bilirubin 1.9 mg/dL (Direct 1.1), Albumin 3.2 g/dL, Total protein 7.9 g/dL", "output": "Interpretation: Abnormal liver enzymes with elevated bilirubin and low albumin, indicating chronic liver damage.\nClinical significance: Suggestive of advanced chronic hepatitis C with evolving cirrhosis.\nFuture risks: Portal hypertension, variceal bleeding, hepatocellular carcinoma, and liver failure.\nLifestyle & follow-up: Avoid alcohol, complete or optimize antiviral therapy, follow with a hepatologist, and undergo regular ultrasound and alpha-fetoprotein screening."}
{"instruction": "Interpret liver function profile", "input": "Female, 55 years, gallstone history\nALT 40 U/L, AST 45 U/L, ALP 260 U/L, GGT 180 U/L, Total bilirubin 3.1 mg/dL (Direct 2.4), Albumin 3.9 g/dL, Total protein 7.4 g/dL", "output": "Interpretation: Cholestatic pattern with conjugated hyperbilirubinemia.\nClinical significance: Strongly suggests extrahepatic biliary obstruction, commonly due to choledocholithiasis (stone in bile duct).\nFuture risks: Acute cholangitis, pancreatitis, and secondary biliary cirrhosis if untreated.\nLifestyle & follow-up: Seek urgent evaluation with imaging (USG/ERCP/MRCP), manage pain and infection as needed, and follow surgical/gastroenterology advice."}
{"instruction": "Interpret liver function profile", "input": "Male, 72 years, long-standing cirrhosis\nALT 26 U/L, AST 40 U/L, ALP 150 U/L, GGT 70 U/L, Total bilirubin 2.9 mg/dL (Direct 2.0), Albumin 2.7 g/dL, Total protein 6.2 g/dL", "output": "Interpretation: Decompensated chronic liver disease with low albumin and raised bilirubin.\nClinical significance: Reflects poor synthetic function and impaired bile excretion in cirrhosis.\nFuture risks: High risk of ascites, hepatic encephalopathy, variceal bleeding, and need for transplantation assessment.\nLifestyle & follow-up: Strict alcohol avoidance, low-sodium diet, adherence to diuretics and other medications, regular follow-up with a hepatologist, and consider transplant evaluation if indicated."}
{"instruction": "Interpret liver function profile", "input": "Female, 38 years\nALT 19 U/L, AST 20 U/L, ALP 100 U/L, GGT 135 U/L, Total bilirubin 0.7 mg/dL (Direct 0.2), Albumin 4.2 g/dL, Total protein 7.4 g/dL", "output": "Interpretation: Isolated elevation in GGT with otherwise normal liver profile.\nClinical significance: May be due to alcohol use, certain medications, or metabolic factors without overt hepatocellular damage.\nFuture risks: If risk factors persist, increased chance of developing fatty liver or other liver disease over time.\nLifestyle & follow-up: Review alcohol intake and medications, optimize weight and metabolic health, and recheck LFTs after lifestyle changes."}
{"instruction": "Interpret liver function profile", "input": "Male, 21 years, athlete\nALT 22 U/L, AST 30 U/L, ALP 110 U/L, GGT 28 U/L, Total bilirubin 1.3 mg/dL (Direct 0.3), Albumin 4.8 g/dL, Total protein 7.8 g/dL", "output": "Interpretation: Mild isolated bilirubin elevation with near-normal enzymes.\nClinical significance: Likely benign unconjugated hyperbilirubinemia, sometimes accentuated by strenuous exercise or fasting.\nFuture risks: Typically benign; no progression to liver disease expected.\nLifestyle & follow-up: Maintain good hydration, avoid prolonged fasting, and monitor only if persistent jaundice or other symptoms occur."}
{"instruction": "Interpret liver function profile", "input": "Female, 60 years, rheumatoid arthritis on methotrexate\nALT 66 U/L, AST 58 U/L, ALP 140 U/L, GGT 75 U/L, Total bilirubin 0.9 mg/dL (Direct 0.3), Albumin 3.9 g/dL, Total protein 7.9 g/dL", "output": "Interpretation: Mild-to-moderate hepatocellular enzyme elevation, possibly drug related.\nClinical significance: Methotrexate can cause chronic hepatic injury and fibrosis.\nFuture risks: Progressive liver damage if hepatotoxic drug exposure continues.\nLifestyle & follow-up: Discuss dose adjustment or drug alternatives with rheumatologist, avoid alcohol, monitor LFTs frequently, and consider imaging or fibrosis assessment if abnormalities persist."}
{"instruction": "Interpret liver function profile", "input": "Male, 47 years, BMI 29\nALT 58 U/L, AST 45 U/L, ALP 120 U/L, GGT 65 U/L, Total bilirubin 0.8 mg/dL (Direct 0.2), Albumin 4.0 g/dL, Total protein 7.2 g/dL", "output": "Interpretation: Mild hepatocellular enzyme elevation, likely related to fatty liver or metabolic strain.\nClinical significance: Common pattern in overweight individuals with insulin resistance.\nFuture risks: NASH, fibrosis, cirrhosis, and cardiometabolic complications over time.\nLifestyle & follow-up: Adopt calorie-controlled, low-sugar diet, increase physical activity, aim for 5–10% weight loss, and repeat LFTs and ultrasound in 3–6 months."}
{"instruction": "Interpret liver function profile", "input": "Female, 33 years, acute right upper quadrant pain\nALT 80 U/L, AST 75 U/L, ALP 260 U/L, GGT 200 U/L, Total bilirubin 2.7 mg/dL (Direct 2.0), Albumin 4.1 g/dL, Total protein 7.3 g/dL", "output": "Interpretation: Mixed hepatocellular and cholestatic pattern with conjugated hyperbilirubinemia.\nClinical significance: Suggests acute biliary obstruction or cholangitis, often from gallstones.\nFuture risks: Sepsis, pancreatitis, and secondary biliary cirrhosis if not treated promptly.\nLifestyle & follow-up: Seek urgent medical care, likely need imaging and possible ERCP/surgery, then maintain a low-fat diet and regular follow-up after treatment."}
{"instruction": "Interpret liver function profile", "input": "Male, 58 years, hypertension\nALT 24 U/L, AST 26 U/L, ALP 105 U/L, GGT 30 U/L, Total bilirubin 0.9 mg/dL (Direct 0.3), Albumin 4.1 g/dL, Total protein 7.1 g/dL", "output": "Interpretation: Liver function tests are within normal limits.\nClinical significance: No evidence of hepatic inflammation or dysfunction.\nFuture risks: Low, though overall cardiovascular risk still depends on blood pressure, lipids, and lifestyle.\nLifestyle & follow-up: Continue blood pressure management, heart-healthy diet, avoid excess alcohol, and include LFTs in periodic health assessments."}
{"instruction": "Interpret liver function profile", "input": "Female, 70 years, frail\nALT 15 U/L, AST 20 U/L, ALP 150 U/L, GGT 40 U/L, Total bilirubin 1.0 mg/dL (Direct 0.4), Albumin 2.9 g/dL, Total protein 6.0 g/dL", "output": "Interpretation: Low albumin and total protein with mildly elevated ALP.\nClinical significance: Suggestive of chronic malnutrition, chronic illness, or liver synthetic dysfunction.\nFuture risks: Poor wound healing, susceptibility to infections, and possible edema or ascites if liver disease is present.\nLifestyle & follow-up: Optimize nutrition (high-protein diet if safe), assess for chronic liver or kidney disease, and work with a physician and dietitian for comprehensive management."}
{"instruction": "Interpret liver function profile", "input": "Male, 36 years, bodybuilding supplements\nALT 95 U/L, AST 82 U/L, ALP 130 U/L, GGT 60 U/L, Total bilirubin 1.3 mg/dL (Direct 0.7), Albumin 4.3 g/dL, Total protein 7.8 g/dL", "output": "Interpretation: Significant hepatocellular enzyme elevation with mild hyperbilirubinemia.\nClinical significance: Possible supplement- or anabolic steroid–induced liver injury.\nFuture risks: Risk of severe drug-induced liver injury, cholestasis, and chronic damage if exposure continues.\nLifestyle & follow-up: Stop all non-essential supplements immediately, avoid alcohol, hydrate well, consult a physician, and monitor LFTs until normalization."}
{"instruction": "Interpret liver function profile", "input": "Female, 44 years, pruritus and fatigue\nALT 40 U/L, AST 42 U/L, ALP 310 U/L, GGT 210 U/L, Total bilirubin 1.6 mg/dL (Direct 1.1), Albumin 3.7 g/dL, Total protein 8.2 g/dL", "output": "Interpretation: Cholestatic enzyme pattern with raised bilirubin and high total protein.\nClinical significance: Could indicate chronic cholestatic disease such as primary biliary cholangitis or sclerosing cholangitis.\nFuture risks: Progressive fibrosis, cirrhosis, fat-soluble vitamin deficiency, and severe itching impacting quality of life.\nLifestyle & follow-up: Avoid alcohol and hepatotoxic drugs, see a hepatologist for autoimmune and cholestatic workup, and adhere to prescribed therapy and follow-up schedule."}
{"instruction": "Interpret liver function profile", "input": "Male, 29 years, acute illness with nausea\nALT 180 U/L, AST 165 U/L, ALP 140 U/L, GGT 70 U/L, Total bilirubin 1.9 mg/dL (Direct 1.0), Albumin 4.0 g/dL, Total protein 7.2 g/dL", "output": "Interpretation: Acute hepatocellular injury with moderate enzyme elevation and mild jaundice.\nClinical significance: Pattern typical of acute viral hepatitis or toxin-induced liver damage.\nFuture risks: Usually self-limited but risk of acute liver failure if coagulopathy or encephalopathy develops.\nLifestyle & follow-up: Seek medical evaluation quickly, avoid alcohol and over-the-counter drugs, rest adequately, maintain hydration, and monitor LFTs and INR closely."}
{"instruction": "Interpret liver function profile", "input": "Female, 50 years, long-term fatty liver\nALT 48 U/L, AST 52 U/L, ALP 125 U/L, GGT 78 U/L, Total bilirubin 1.0 mg/dL (Direct 0.4), Albumin 3.8 g/dL, Total protein 7.3 g/dL", "output": "Interpretation: Mild chronic hepatocellular elevation consistent with stable fatty liver disease.\nClinical significance: Indicates ongoing low-grade liver inflammation.\nFuture risks: Over years, risk of fibrosis, cirrhosis, and hepatocellular carcinoma, especially with diabetes or obesity.\nLifestyle & follow-up: Tight control of weight, blood sugar, and lipids, regular exercise, avoid alcohol, and periodic LFTs and imaging to monitor progression."}
{"instruction": "Interpret liver function profile", "input": "Male, 63 years, smoker\nALT 23 U/L, AST 26 U/L, ALP 135 U/L, GGT 55 U/L, Total bilirubin 0.8 mg/dL (Direct 0.3), Albumin 4.0 g/dL, Total protein 7.1 g/dL", "output": "Interpretation: Mildly raised ALP and GGT with otherwise normal parameters.\nClinical significance: May reflect low-grade cholestasis, metabolic factors, or medication effects.\nFuture risks: Possible progression to clinically significant liver or biliary disease if risk factors continue.\nLifestyle & follow-up: Stop smoking, limit alcohol, review medications, maintain a healthy weight, and repeat LFTs and possibly ultrasound if abnormalities persist."}
{"instruction": "Interpret liver function profile", "input": "Female, 26 years, recent viral infection\nALT 70 U/L, AST 65 U/L, ALP 110 U/L, GGT 42 U/L, Total bilirubin 0.9 mg/dL (Direct 0.4), Albumin 4.3 g/dL, Total protein 7.5 g/dL", "output": "Interpretation: Mild hepatocellular enzyme elevation following a recent viral illness.\nClinical significance: Likely transient viral-related hepatitis or post-infectious enzyme rise.\nFuture risks: Usually minimal; enzymes often normalize.\nLifestyle & follow-up: Rest, avoid alcohol and unnecessary medication, maintain hydration, and recheck LFTs in 4–6 weeks to confirm normalization."}
{"instruction": "Interpret liver function profile", "input": "Male, 52 years, chronic heart failure\nALT 33 U/L, AST 38 U/L, ALP 160 U/L, GGT 70 U/L, Total bilirubin 1.5 mg/dL (Direct 0.8), Albumin 3.4 g/dL, Total protein 7.0 g/dL", "output": "Interpretation: Mild to moderate mixed enzyme elevation with slightly low albumin.\nClinical significance: May represent congestive hepatopathy (liver congestion) due to heart failure.\nFuture risks: Progressive liver dysfunction if heart failure is poorly controlled.\nLifestyle & follow-up: Optimize heart failure management (medications, salt restriction, fluid control), avoid alcohol, and monitor LFTs and cardiac status regularly."}
{"instruction": "Interpret liver function profile","input":"ALT 68 U/L, AST 72 U/L, ALP 110 U/L, GGT 85 U/L, Total bilirubin 1.6 mg/dL, Direct bilirubin 0.4 mg/dL, Albumin 4.2 g/dL, Total protein 7.1 g/dL","output":"Interpretation: Mild hepatocellular injury.\nClinical significance: Elevated ALT/AST suggests liver inflammation, likely due to fatty liver or early hepatitis.\nFuture risks: Progression to NASH, fibrosis, or cirrhosis if persistent.\nLifestyle & follow-up: Reduce alcohol, improve diet, weight management, repeat LFTs in 6–8 weeks."}
{"instruction": "Interpret liver function profile","input":"ALT 22 U/L, AST 24 U/L, ALP 72 U/L, GGT 20 U/L, Total bilirubin 0.8 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.6 g/dL, Total protein 7.5 g/dL","output":"Interpretation: Normal liver profile.\nClinical significance: All parameters are within reference ranges.\nFuture risks: No immediate hepatic concerns.\nLifestyle & follow-up: Maintain balanced diet and hydration, routine annual checkup."}
{"instruction": "Interpret liver function profile","input":"ALT 145 U/L, AST 162 U/L, ALP 210 U/L, GGT 320 U/L, Total bilirubin 2.8 mg/dL, Direct bilirubin 1.1 mg/dL, Albumin 3.4 g/dL, Total protein 6.2 g/dL","output":"Interpretation: Severe hepatocellular and cholestatic injury.\nClinical significance: Pattern suggests significant liver inflammation—consider alcoholic hepatitis, drug-induced injury, or viral hepatitis.\nFuture risks: Jaundice progression, hepatic failure, cirrhosis.\nLifestyle & follow-up: Immediate medical evaluation required, ultrasound, viral profile, strict alcohol cessation."}
{"instruction": "Interpret liver function profile","input":"ALT 35 U/L, AST 40 U/L, ALP 130 U/L, GGT 150 U/L, Total bilirubin 0.9 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 4.3 g/dL, Total protein 7.0 g/dL","output":"Interpretation: Isolated cholestatic enzyme elevation.\nClinical significance: Elevated ALP/GGT suggests biliary involvement—possible gallstone, obstruction, or fatty liver.\nFuture risks: Biliary obstruction, gallbladder disease progression.\nLifestyle & follow-up: Abdominal ultrasound recommended, low-fat diet, monitor symptoms."}
{"instruction": "Interpret liver function profile","input":"ALT 18 U/L, AST 21 U/L, ALP 65 U/L, GGT 18 U/L, Total bilirubin 0.6 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.7 g/dL, Total protein 7.8 g/dL","output":"Interpretation: Completely normal liver function.\nClinical significance: No hepatic pathology indicated.\nFuture risks: Minimal risk if lifestyle is healthy.\nLifestyle & follow-up: Routine screenings yearly."}
{"instruction": "Interpret liver function profile","input":"ALT 210 U/L, AST 195 U/L, ALP 165 U/L, GGT 100 U/L, Total bilirubin 1.2 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 3.8 g/dL, Total protein 6.5 g/dL","output":"Interpretation: Marked hepatocellular injury.\nClinical significance: High ALT/AST indicates active liver damage—consider viral hepatitis, NAFLD, toxins.\nFuture risks: Fibrosis development.\nLifestyle & follow-up: Hepatitis profile, avoid hepatotoxic medications, weight loss if overweight."}
{"instruction": "Interpret liver function profile","input":"ALT 90 U/L, AST 55 U/L, ALP 102 U/L, GGT 60 U/L, Total bilirubin 0.8 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.1 g/dL, Total protein 7.3 g/dL","output":"Interpretation: Mild ALT-predominant elevation.\nClinical significance: Suggestive of early fatty liver disease.\nFuture risks: Insulin resistance, NASH.\nLifestyle & follow-up: Increase physical activity, limit sugar/alcohol, recheck in 3 months."}
{"instruction": "Interpret liver function profile","input":"ALT 28 U/L, AST 30 U/L, ALP 155 U/L, GGT 210 U/L, Total bilirubin 1.0 mg/dL, Direct bilirubin 0.4 mg/dL, Albumin 4.5 g/dL, Total protein 7.6 g/dL","output":"Interpretation: Predominantly cholestatic elevation.\nClinical significance: Elevated ALP/GGT suggests biliary obstruction or cholestasis.\nFuture risks: Gallstone disease, cholangitis.\nLifestyle & follow-up: Ultrasound, avoid fatty meals, urgent review if jaundice develops."}
{"instruction": "Interpret liver function profile","input":"ALT 10 U/L, AST 15 U/L, ALP 98 U/L, GGT 12 U/L, Total bilirubin 0.5 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.8 g/dL, Total protein 7.9 g/dL","output":"Interpretation: Normal liver enzymes.\nClinical significance: Healthy liver function.\nFuture risks: None.\nLifestyle & follow-up: Continue healthy routine."}
{"instruction": "Interpret liver function profile","input":"ALT 320 U/L, AST 290 U/L, ALP 140 U/L, GGT 250 U/L, Total bilirubin 3.6 mg/dL, Direct bilirubin 1.5 mg/dL, Albumin 3.2 g/dL, Total protein 6.1 g/dL","output":"Interpretation: Severe hepatocellular damage with jaundice.\nClinical significance: Highly suggestive of acute hepatitis.\nFuture risks: Acute liver failure, coagulopathy.\nLifestyle & follow-up: Emergency specialist evaluation, coagulation profile, imaging."}
{"instruction":"Interpret liver function profile","input":"ALT 46 U/L, AST 40 U/L, ALP 122 U/L, GGT 88 U/L, Total bilirubin 1.1 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 4.0 g/dL, Total protein 6.8 g/dL","output":"Interpretation: Mild mixed liver enzyme elevation.\nClinical significance: Pattern may indicate early biliary irritation or nonalcoholic fatty liver.\nFuture risks: Progression to gallbladder disease or fatty liver complications.\nLifestyle & follow-up: Reduce oily foods, moderate alcohol, repeat LFTs in 6–8 weeks."}
{"instruction":"Interpret liver function profile","input":"ALT 14 U/L, AST 18 U/L, ALP 68 U/L, GGT 22 U/L, Total bilirubin 0.7 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.4 g/dL, Total protein 7.4 g/dL","output":"Interpretation: Normal liver profile.\nClinical significance: No indication of hepatic inflammation or cholestasis.\nFuture risks: No immediate risks.\nLifestyle & follow-up: Continue healthy lifestyle, annual monitoring."}
{"instruction":"Interpret liver function profile","input":"ALT 185 U/L, AST 165 U/L, ALP 250 U/L, GGT 310 U/L, Total bilirubin 2.4 mg/dL, Direct bilirubin 0.9 mg/dL, Albumin 3.5 g/dL, Total protein 6.0 g/dL","output":"Interpretation: Moderate hepatocellular and cholestatic injury.\nClinical significance: Could indicate viral hepatitis, drug-induced injury, or alcoholic liver disease.\nFuture risks: Fibrosis, impaired detoxification, cirrhosis.\nLifestyle & follow-up: Stop alcohol, test viral markers, ultrasound, hepatology referral."}
{"instruction":"Interpret liver function profile","input":"ALT 52 U/L, AST 43 U/L, ALP 85 U/L, GGT 41 U/L, Total bilirubin 1.0 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 4.3 g/dL, Total protein 7.2 g/dL","output":"Interpretation: Mild ALT predominance.\nClinical significance: Suggestive of mild fatty liver or early inflammatory changes.\nFuture risks: Insulin resistance, metabolic syndrome.\nLifestyle & follow-up: Weight reduction, exercise, repeat tests in 2–3 months."}
{"instruction":"Interpret liver function profile","input":"ALT 25 U/L, AST 26 U/L, ALP 210 U/L, GGT 260 U/L, Total bilirubin 0.9 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.1 g/dL, Total protein 7.0 g/dL","output":"Interpretation: Elevated ALP/GGT indicates cholestasis.\nClinical significance: Possible gallstones, bile duct obstruction, or primary biliary conditions.\nFuture risks: Jaundice, cholangitis.\nLifestyle & follow-up: Ultrasound recommended, avoid fatty meals, monitor for abdominal pain."}
{"instruction":"Interpret liver function profile","input":"ALT 305 U/L, AST 280 U/L, ALP 110 U/L, GGT 130 U/L, Total bilirubin 3.1 mg/dL, Direct bilirubin 1.3 mg/dL, Albumin 3.0 g/dL, Total protein 6.0 g/dL","output":"Interpretation: Marked liver cell injury with jaundice.\nClinical significance: Strongly suggests acute hepatitis or toxin-induced injury.\nFuture risks: Hepatic failure.\nLifestyle & follow-up: Immediate hospital evaluation, viral serology, INR, supportive care."}
{"instruction":"Interpret liver function profile","input":"ALT 40 U/L, AST 37 U/L, ALP 150 U/L, GGT 190 U/L, Total bilirubin 1.3 mg/dL, Direct bilirubin 0.4 mg/dL, Albumin 3.9 g/dL, Total protein 6.9 g/dL","output":"Interpretation: Cholestatic elevation with mildly high bilirubin.\nClinical significance: May indicate biliary stasis or obstruction.\nFuture risks: Liver inflammation, gallbladder complications.\nLifestyle & follow-up: Abdominal ultrasound, hydration, avoid alcohol."}
{"instruction":"Interpret liver function profile","input":"ALT 12 U/L, AST 14 U/L, ALP 60 U/L, GGT 15 U/L, Total bilirubin 0.4 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.9 g/dL, Total protein 7.6 g/dL","output":"Interpretation: Optimal liver function.\nClinical significance: No signs of hepatic or biliary abnormality.\nFuture risks: None.\nLifestyle & follow-up: Maintain current routine."}
{"instruction":"Interpret liver function profile","input":"ALT 160 U/L, AST 140 U/L, ALP 130 U/L, GGT 175 U/L, Total bilirubin 1.5 mg/dL, Direct bilirubin 0.5 mg/dL, Albumin 3.6 g/dL, Total protein 6.3 g/dL","output":"Interpretation: Mixed pattern elevation.\nClinical significance: Could reflect alcoholic liver disease or toxic injury.\nFuture risks: Pancreatic stress, cirrhosis.\nLifestyle & follow-up: Alcohol cessation mandatory, repeat LFTs in 4–6 weeks."}
{"instruction":"Interpret liver function profile","input":"ALT 28 U/L, AST 26 U/L, ALP 300 U/L, GGT 320 U/L, Total bilirubin 1.2 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 4.0 g/dL, Total protein 7.1 g/dL","output":"Interpretation: Significant cholestatic enzyme elevation.\nClinical significance: Suggests biliary obstruction from gallstones or cholestatic liver disease.\nFuture risks: Cholangitis, worsening jaundice.\nLifestyle & follow-up: Ultrasound urgently, surgical consult if stones confirmed."}
{"instruction":"Interpret liver function profile","input":"ALT 45 U/L, AST 38 U/L, ALP 140 U/L, GGT 160 U/L, Total bilirubin 0.9 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.2 g/dL, Total protein 7.0 g/dL","output":"Interpretation: Mild cholestatic elevation.\nClinical significance: Suggestive of early bile flow impairment or fatty liver involvement.\nFuture risks: Gallstone formation, metabolic dysfunction.\nLifestyle & follow-up: Reduce fat intake, increase hydration, consider abdominal ultrasound."}
{"instruction":"Interpret liver function profile","input":"ALT 26 U/L, AST 24 U/L, ALP 200 U/L, GGT 215 U/L, Total bilirubin 1.0 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 4.1 g/dL, Total protein 6.9 g/dL","output":"Interpretation: Cholestasis pattern with elevated ALP and GGT.\nClinical significance: Possible obstruction or primary biliary inflammation.\nFuture risks: Jaundice progression, chronic cholestasis.\nLifestyle & follow-up: Ultrasound recommended, avoid alcohol, monitor for pruritus."}
{"instruction":"Interpret liver function profile","input":"ALT 33 U/L, AST 30 U/L, ALP 135 U/L, GGT 55 U/L, Total bilirubin 0.8 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.5 g/dL, Total protein 7.3 g/dL","output":"Interpretation: Mild isolated ALP elevation.\nClinical significance: Could indicate bone turnover, mild biliary irritation.\nFuture risks: None significant unless progressive.\nLifestyle & follow-up: Re-check ALP with GGT, ensure vitamin D sufficiency."}
{"instruction":"Interpret liver function profile","input":"ALT 72 U/L, AST 59 U/L, ALP 95 U/L, GGT 50 U/L, Total bilirubin 0.7 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.0 g/dL, Total protein 6.8 g/dL","output":"Interpretation: Mild hepatocellular enzyme elevation.\nClinical significance: Early fatty liver or transient inflammation.\nFuture risks: Insulin resistance, NAFLD progression.\nLifestyle & follow-up: Weight control, avoid sugary foods, repeat LFTs in 2 months."}
{"instruction":"Interpret liver function profile","input":"ALT 12 U/L, AST 15 U/L, ALP 240 U/L, GGT 260 U/L, Total bilirubin 1.4 mg/dL, Direct bilirubin 0.4 mg/dL, Albumin 3.9 g/dL, Total protein 7.1 g/dL","output":"Interpretation: Significant cholestatic enzyme elevation.\nClinical significance: Strongly suggests biliary obstruction or gallbladder inflammation.\nFuture risks: Jaundice, ascending cholangitis.\nLifestyle & follow-up: Seek imaging promptly, avoid heavy meals, surgical consult if gallstones present."}
{"instruction":"Interpret liver function profile","input":"ALT 200 U/L, AST 175 U/L, ALP 105 U/L, GGT 130 U/L, Total bilirubin 2.2 mg/dL, Direct bilirubin 0.8 mg/dL, Albumin 3.2 g/dL, Total protein 6.1 g/dL","output":"Interpretation: Moderate hepatocellular injury with bilirubin elevation.\nClinical significance: Likely viral hepatitis, medication toxicity, or alcohol damage.\nFuture risks: Hepatic failure or fibrosis if untreated.\nLifestyle & follow-up: Immediate medical evaluation, viral hepatitis testing, alcohol cessation."}
{"instruction":"Interpret liver function profile","input":"ALT 29 U/L, AST 32 U/L, ALP 115 U/L, GGT 145 U/L, Total bilirubin 1.1 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 4.3 g/dL, Total protein 7.0 g/dL","output":"Interpretation: Mild GGT elevation.\nClinical significance: Often associated with alcohol use or early fatty liver.\nFuture risks: Hepatic steatosis progression.\nLifestyle & follow-up: Reduce alcohol, adopt low-fat diet, exercise regularly."}
{"instruction":"Interpret liver function profile","input":"ALT 350 U/L, AST 310 U/L, ALP 160 U/L, GGT 190 U/L, Total bilirubin 3.0 mg/dL, Direct bilirubin 1.1 mg/dL, Albumin 2.9 g/dL, Total protein 5.9 g/dL","output":"Interpretation: Severe hepatocellular injury with jaundice.\nClinical significance: Consistent with acute hepatitis or drug-induced liver damage.\nFuture risks: Acute liver failure.\nLifestyle & follow-up: Emergency evaluation required, INR check, discontinue suspect medications."}
{"instruction":"Interpret liver function profile","input":"ALT 21 U/L, AST 19 U/L, ALP 155 U/L, GGT 170 U/L, Total bilirubin 0.8 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.2 g/dL, Total protein 6.9 g/dL","output":"Interpretation: Early cholestatic pattern.\nClinical significance: Possible early biliary obstruction or fatty liver.\nFuture risks: Gallstone complications.\nLifestyle & follow-up: Hydrate well, limit fried foods, follow-up ultrasound advised."}
{"instruction":"Interpret liver function profile","input":"ALT 27 U/L, AST 24 U/L, ALP 90 U/L, GGT 22 U/L, Total bilirubin 0.5 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.6 g/dL, Total protein 7.4 g/dL","output":"Interpretation: Completely normal liver profile.\nClinical significance: No signs of liver or biliary disease.\nFuture risks: None.\nLifestyle & follow-up: Maintain healthy habits, annual LFT recommended."}
{"instruction":"Interpret liver function profile","input":"ALT 62 U/L, AST 49 U/L, ALP 102 U/L, GGT 118 U/L, Total bilirubin 0.9 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.0 g/dL, Total protein 6.6 g/dL","output":"Interpretation: Mild hepatocellular enzyme elevation.\nClinical significance: Suggestive of early fatty liver or metabolic inflammation.\nFuture risks: Insulin resistance, NAFLD progression.\nLifestyle & follow-up: Weight management, reduce refined carbs, repeat LFT in 8–12 weeks."}
{"instruction":"Interpret liver function profile","input":"ALT 22 U/L, AST 20 U/L, ALP 170 U/L, GGT 185 U/L, Total bilirubin 1.2 mg/dL, Direct bilirubin 0.4 mg/dL, Albumin 3.9 g/dL, Total protein 7.2 g/dL","output":"Interpretation: Cholestatic pattern with elevated ALP and GGT.\nClinical significance: Likely biliary obstruction or gallbladder inflammation.\nFuture risks: Jaundice, gallstone-related complications.\nLifestyle & follow-up: Ultrasound recommended, increase hydration, avoid heavy/fatty meals."}
{"instruction":"Interpret liver function profile","input":"ALT 15 U/L, AST 18 U/L, ALP 225 U/L, GGT 240 U/L, Total bilirubin 1.4 mg/dL, Direct bilirubin 0.5 mg/dL, Albumin 4.1 g/dL, Total protein 6.7 g/dL","output":"Interpretation: Marked cholestatic enzyme elevations.\nClinical significance: Strong suspicion of bile duct obstruction or primary biliary disease.\nFuture risks: Ascending cholangitis, worsening jaundice.\nLifestyle & follow-up: Immediate imaging, avoid alcohol, monitor for fever or abdominal pain."}
{"instruction":"Interpret liver function profile","input":"ALT 140 U/L, AST 110 U/L, ALP 98 U/L, GGT 80 U/L, Total bilirubin 0.7 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 3.8 g/dL, Total protein 6.5 g/dL","output":"Interpretation: Hepatocellular injury pattern.\nClinical significance: Possible viral hepatitis, drug-induced injury, or fatty liver.\nFuture risks: Fibrosis if persistent.\nLifestyle & follow-up: Discontinue hepatotoxic drugs, hepatitis screening, avoid alcohol fully."}
{"instruction":"Interpret liver function profile","input":"ALT 38 U/L, AST 33 U/L, ALP 130 U/L, GGT 160 U/L, Total bilirubin 0.6 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.5 g/dL, Total protein 7.2 g/dL","output":"Interpretation: GGT elevation with mild ALP rise.\nClinical significance: Early alcoholic or fatty liver changes.\nFuture risks: Progression to steatohepatitis.\nLifestyle & follow-up: Eliminate alcohol, increase physical activity, repeat liver enzymes in 2–3 months."}
{"instruction":"Interpret liver function profile","input":"ALT 310 U/L, AST 275 U/L, ALP 120 U/L, GGT 145 U/L, Total bilirubin 2.8 mg/dL, Direct bilirubin 0.9 mg/dL, Albumin 3.0 g/dL, Total protein 6.1 g/dL","output":"Interpretation: Severe hepatocellular injury with jaundice.\nClinical significance: Likely acute hepatitis or toxin-induced liver damage.\nFuture risks: Acute liver failure.\nLifestyle & follow-up: Emergency evaluation, coagulation profile, stop all non-essential medications."}
{"instruction":"Interpret liver function profile","input":"ALT 25 U/L, AST 23 U/L, ALP 160 U/L, GGT 35 U/L, Total bilirubin 0.8 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.3 g/dL, Total protein 7.0 g/dL","output":"Interpretation: Isolated ALP elevation.\nClinical significance: May reflect bone turnover or mild biliary irritation.\nFuture risks: Minimal unless persistent.\nLifestyle & follow-up: Recheck ALP with GGT, evaluate vitamin D levels."}
{"instruction":"Interpret liver function profile","input":"ALT 29 U/L, AST 27 U/L, ALP 150 U/L, GGT 175 U/L, Total bilirubin 1.1 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 4.1 g/dL, Total protein 6.9 g/dL","output":"Interpretation: Cholestatic liver enzyme pattern.\nClinical significance: Suggestive of biliary obstruction or chronic inflammation.\nFuture risks: Gallstone-related complications.\nLifestyle & follow-up: Schedule ultrasound, reduce high-fat foods, stay well hydrated."}
{"instruction":"Interpret liver function profile","input":"ALT 410 U/L, AST 380 U/L, ALP 240 U/L, GGT 260 U/L, Total bilirubin 3.5 mg/dL, Direct bilirubin 1.4 mg/dL, Albumin 2.8 g/dL, Total protein 5.8 g/dL","output":"Interpretation: Severe mixed hepatocellular and cholestatic injury.\nClinical significance: Strongly concerning for acute hepatitis, drug toxicity, or obstruction with liver inflammation.\nFuture risks: Liver failure, coagulopathy.\nLifestyle & follow-up: Immediate hospitalization, INR check, imaging, and viral hepatitis testing."}
{"instruction":"Interpret liver function profile","input":"ALT 18 U/L, AST 20 U/L, ALP 95 U/L, GGT 18 U/L, Total bilirubin 0.4 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.7 g/dL, Total protein 7.5 g/dL","output":"Interpretation: Normal liver function profile.\nClinical significance: No evidence of liver or biliary disease.\nFuture risks: None.\nLifestyle & follow-up: Continue healthy lifestyle, yearly monitoring is sufficient."}
{"instruction":"Interpret liver function profile","input":"ALT 75 U/L, AST 54 U/L, ALP 112 U/L, GGT 130 U/L, Total bilirubin 1.0 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 3.7 g/dL, Total protein 6.4 g/dL","output":"Interpretation: Mild hepatocellular injury with cholestatic involvement.\nClinical significance: Suggests early NAFLD or alcohol-related inflammation.\nFuture risks: Fibrosis if persistent.\nLifestyle & follow-up: Reduce sugars, eliminate alcohol, repeat LFT in 2 months."}
{"instruction":"Interpret liver function profile","input":"ALT 19 U/L, AST 18 U/L, ALP 260 U/L, GGT 220 U/L, Total bilirubin 0.9 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.0 g/dL, Total protein 7.0 g/dL","output":"Interpretation: Significant cholestatic enzyme elevation.\nClinical significance: Possible bile duct obstruction or drug-induced cholestasis.\nFuture risks: Recurrent jaundice, biliary infection.\nLifestyle & follow-up: Perform abdominal ultrasound, reduce fatty meals, review medications."}
{"instruction":"Interpret liver function profile","input":"ALT 35 U/L, AST 30 U/L, ALP 180 U/L, GGT 40 U/L, Total bilirubin 0.7 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.5 g/dL, Total protein 7.4 g/dL","output":"Interpretation: Isolated ALP elevation.\nClinical significance: More likely bone-related than liver-related.\nFuture risks: Vitamin D deficiency or bone turnover disorders.\nLifestyle & follow-up: Check vitamin D and calcium, recheck ALP in 6–8 weeks."}
{"instruction":"Interpret liver function profile","input":"ALT 210 U/L, AST 190 U/L, ALP 130 U/L, GGT 115 U/L, Total bilirubin 1.6 mg/dL, Direct bilirubin 0.5 mg/dL, Albumin 3.5 g/dL, Total protein 6.2 g/dL","output":"Interpretation: Marked hepatocellular injury.\nClinical significance: Viral hepatitis or drug-induced liver injury possible.\nFuture risks: Inflammation progressing to fibrosis.\nLifestyle & follow-up: Immediate hepatitis testing, avoid alcohol and paracetamol, repeat LFT in 1–2 weeks."}
{"instruction":"Interpret liver function profile","input":"ALT 25 U/L, AST 22 U/L, ALP 145 U/L, GGT 160 U/L, Total bilirubin 0.8 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 4.2 g/dL, Total protein 7.1 g/dL","output":"Interpretation: Cholestatic pattern mainly due to GGT elevation.\nClinical significance: Suggestive of fatty liver or alcohol-related stress.\nFuture risks: Progression to NASH.\nLifestyle & follow-up: Avoid alcohol, maintain healthy weight, re-evaluate liver enzymes in 3 months."}
{"instruction":"Interpret liver function profile","input":"ALT 430 U/L, AST 410 U/L, ALP 210 U/L, GGT 250 U/L, Total bilirubin 3.0 mg/dL, Direct bilirubin 0.9 mg/dL, Albumin 2.9 g/dL, Total protein 5.9 g/dL","output":"Interpretation: Severe mixed liver injury.\nClinical significance: Suggests acute hepatitis, toxic liver injury, or obstructive pathology.\nFuture risks: Acute liver failure.\nLifestyle & follow-up: Emergency evaluation, coagulation profile, viral markers, and abdominal imaging required."}
{"instruction":"Interpret liver function profile","input":"ALT 14 U/L, AST 16 U/L, ALP 90 U/L, GGT 20 U/L, Total bilirubin 0.6 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.8 g/dL, Total protein 7.6 g/dL","output":"Interpretation: Fully normal liver profile.\nClinical significance: No evidence of liver dysfunction.\nFuture risks: None.\nLifestyle & follow-up: Continue balanced diet, annual preventive check is sufficient."}
{"instruction":"Interpret liver function profile","input":"ALT 68 U/L, AST 60 U/L, ALP 135 U/L, GGT 140 U/L, Total bilirubin 1.0 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.0 g/dL, Total protein 6.8 g/dL","output":"Interpretation: Mixed mild liver enzyme elevation.\nClinical significance: Possibly early NAFLD or metabolic syndrome.\nFuture risks: Pre-diabetes, hepatic steatosis worsening.\nLifestyle & follow-up: Low-sugar diet, exercise 30 min/day, repeat LFTs in 2 months."}
{"instruction":"Interpret liver function profile","input":"ALT 300 U/L, AST 260 U/L, ALP 145 U/L, GGT 160 U/L, Total bilirubin 2.1 mg/dL, Direct bilirubin 0.8 mg/dL, Albumin 3.2 g/dL, Total protein 6.1 g/dL","output":"Interpretation: Significant hepatocellular damage.\nClinical significance: Could indicate viral hepatitis, autoimmune hepatitis, or medication toxicity.\nFuture risks: Progression to chronic liver disease.\nLifestyle & follow-up: Stop hepatotoxic medications, order viral hepatitis profile, consider autoimmune workup."}
{"instruction":"Interpret liver function profile","input":"ALT 28 U/L, AST 24 U/L, ALP 170 U/L, GGT 22 U/L, Total bilirubin 0.9 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.6 g/dL, Total protein 7.3 g/dL","output":"Interpretation: Mild ALP elevation with normal GGT.\nClinical significance: Bone-related cause likely; liver origin less likely.\nFuture risks: Osteopenia/osteoporosis.\nLifestyle & follow-up: Check vitamin D, calcium, consider bone density scan if symptomatic."}
{"instruction":"Interpret liver function profile","input":"ALT 92 U/L, AST 70 U/L, ALP 128 U/L, GGT 165 U/L, Total bilirubin 1.3 mg/dL, Direct bilirubin 0.4 mg/dL, Albumin 3.8 g/dL, Total protein 6.6 g/dL","output":"Interpretation: Mild-to-moderate hepatocellular injury with cholestasis.\nClinical significance: Suggestive of alcoholic liver stress or fatty liver.\nFuture risks: Progression to steatohepatitis.\nLifestyle & follow-up: Avoid alcohol, reduce sugars, repeat LFTs in 6 weeks."}
{"instruction":"Interpret liver function profile","input":"ALT 40 U/L, AST 37 U/L, ALP 190 U/L, GGT 22 U/L, Total bilirubin 0.6 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.3 g/dL, Total protein 7.0 g/dL","output":"Interpretation: Isolated ALP elevation.\nClinical significance: Likely bone-related rather than liver disease.\nFuture risks: Vitamin D deficiency or bone turnover disorders.\nLifestyle & follow-up: Check vitamin D and PTH, monitor ALP."}
{"instruction":"Interpret liver function profile","input":"ALT 150 U/L, AST 130 U/L, ALP 140 U/L, GGT 180 U/L, Total bilirubin 1.5 mg/dL, Direct bilirubin 0.5 mg/dL, Albumin 3.4 g/dL, Total protein 6.3 g/dL","output":"Interpretation: Significant liver inflammation.\nClinical significance: Suspicious for NAFLD, hepatitis, or drug toxicity.\nFuture risks: Fibrosis if untreated.\nLifestyle & follow-up: Weight control, avoid alcohol, hepatitis profile recommended."}
{"instruction":"Interpret liver function profile","input":"ALT 16 U/L, AST 20 U/L, ALP 83 U/L, GGT 18 U/L, Total bilirubin 0.7 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.6 g/dL, Total protein 7.5 g/dL","output":"Interpretation: Completely normal liver profile.\nClinical significance: Healthy liver function.\nFuture risks: None.\nLifestyle & follow-up: Maintain healthy habits."}
{"instruction":"Interpret liver function profile","input":"ALT 244 U/L, AST 198 U/L, ALP 198 U/L, GGT 240 U/L, Total bilirubin 2.6 mg/dL, Direct bilirubin 0.9 mg/dL, Albumin 3.1 g/dL, Total protein 6.1 g/dL","output":"Interpretation: Severe mixed liver injury.\nClinical significance: Possible acute hepatitis or bile duct obstruction.\nFuture risks: Acute liver failure if untreated.\nLifestyle & follow-up: Urgent imaging and viral/autoimmune testing needed."}
{"instruction":"Interpret liver function profile","input":"ALT 31 U/L, AST 28 U/L, ALP 115 U/L, GGT 84 U/L, Total bilirubin 0.8 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 3.9 g/dL, Total protein 6.8 g/dL","output":"Interpretation: Mild cholestatic pattern.\nClinical significance: Could indicate early NAFLD.\nFuture risks: Potential metabolic syndrome development.\nLifestyle & follow-up: Increase physical activity, low-carb diet, recheck LFTs in 8 weeks."}
{"instruction":"Interpret liver function profile","input":"ALT 105 U/L, AST 98 U/L, ALP 110 U/L, GGT 160 U/L, Total bilirubin 1.1 mg/dL, Direct bilirubin 0.4 mg/dL, Albumin 3.7 g/dL, Total protein 6.5 g/dL","output":"Interpretation: Elevated liver enzymes suggest inflammation.\nClinical significance: Fatty liver or alcohol-related injury.\nFuture risks: Liver fibrosis.\nLifestyle & follow-up: Reduce alcohol, follow Mediterranean diet."}
{"instruction":"Interpret liver function profile","input":"ALT 410 U/L, AST 455 U/L, ALP 150 U/L, GGT 130 U/L, Total bilirubin 3.1 mg/dL, Direct bilirubin 1.0 mg/dL, Albumin 2.8 g/dL, Total protein 5.7 g/dL","output":"Interpretation: Marked hepatic injury.\nClinical significance: Strong suspicion of acute viral or autoimmune hepatitis.\nFuture risks: Risk of liver failure.\nLifestyle & follow-up: Immediate medical evaluation required."}
{"instruction":"Interpret liver function profile","input":"ALT 65 U/L, AST 58 U/L, ALP 92 U/L, GGT 180 U/L, Total bilirubin 0.9 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.0 g/dL, Total protein 7.0 g/dL","output":"Interpretation: GGT selectively elevated.\nClinical significance: Indicates alcohol-related enzyme induction.\nFuture risks: Steatohepatitis.\nLifestyle & follow-up: Avoid alcohol fully for 3 months; repeat test."}
{"instruction":"Interpret liver function profile","input":"ALT 37 U/L, AST 33 U/L, ALP 210 U/L, GGT 25 U/L, Total bilirubin 0.6 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.7 g/dL, Total protein 7.3 g/dL","output":"Interpretation: ALP elevated likely from bone origin.\nClinical significance: Possibly vitamin D deficiency.\nFuture risks: Osteopenia.\nLifestyle & follow-up: Check vitamin D and calcium."}
{"instruction":"Interpret liver function profile","input":"ALT 155 U/L, AST 180 U/L, ALP 200 U/L, GGT 230 U/L, Total bilirubin 1.7 mg/dL, Direct bilirubin 0.5 mg/dL, Albumin 3.3 g/dL, Total protein 6.2 g/dL","output":"Interpretation: Severe mixed enzyme elevation.\nClinical significance: Suggestive of toxic liver injury.\nFuture risks: Rapid fibrosis risk.\nLifestyle & follow-up: Stop hepatotoxic drugs, urgent specialist review."}
{"instruction":"Interpret liver function profile","input":"ALT 25 U/L, AST 22 U/L, ALP 87 U/L, GGT 19 U/L, Total bilirubin 0.5 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 5.0 g/dL, Total protein 7.6 g/dL","output":"Interpretation: Normal liver function.\nClinical significance: No disease detected.\nFuture risks: Minimal.\nLifestyle & follow-up: Continue healthy diet."}
{"instruction":"Interpret liver function profile","input":"ALT 85 U/L, AST 60 U/L, ALP 132 U/L, GGT 150 U/L, Total bilirubin 1.2 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 3.8 g/dL, Total protein 6.7 g/dL","output":"Interpretation: Mild hepatocellular and cholestatic elevation.\nClinical significance: Early alcohol injury or NAFLD.\nFuture risks: Chronic liver inflammation.\nLifestyle & follow-up: Weight loss, stop alcohol, repeat LFTs."}
{"instruction":"Interpret liver function profile","input":"ALT 44 U/L, AST 39 U/L, ALP 160 U/L, GGT 140 U/L, Total bilirubin 1.0 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 4.1 g/dL, Total protein 6.9 g/dL","output":"Interpretation: Mild cholestasis.\nClinical significance: Early biliary obstruction possible.\nFuture risks: Gallstones or cholangitis.\nLifestyle & follow-up: Ultrasound abdomen recommended."}
{"instruction":"Interpret liver function profile","input":"ALT 25 U/L, AST 20 U/L, ALP 102 U/L, GGT 22 U/L, Total bilirubin 0.9 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.4 g/dL, Total protein 7.2 g/dL","output":"Interpretation: Normal liver enzymes.\nClinical significance: Healthy function.\nFuture risks: None.\nLifestyle & follow-up: Routine monitoring only."}
{"instruction":"Interpret liver function profile","input":"ALT 299 U/L, AST 310 U/L, ALP 180 U/L, GGT 250 U/L, Total bilirubin 2.2 mg/dL, Direct bilirubin 0.8 mg/dL, Albumin 3.0 g/dL, Total protein 6.1 g/dL","output":"Interpretation: Marked hepatocellular injury.\nClinical significance: Acute hepatitis or significant toxin exposure.\nFuture risks: Hepatic failure.\nLifestyle & follow-up: Immediate specialist consultation required."}
{"instruction":"Interpret liver function profile","input":"ALT 70 U/L, AST 55 U/L, ALP 125 U/L, GGT 170 U/L, Total bilirubin 1.1 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 3.9 g/dL, Total protein 6.4 g/dL","output":"Interpretation: Mixed pattern.\nClinical significance: Fatty liver or alcohol effect.\nFuture risks: Fibrosis.\nLifestyle & follow-up: Avoid alcohol; Mediterranean diet advised."}
{"instruction":"Interpret liver function profile","input":"ALT 17 U/L, AST 19 U/L, ALP 220 U/L, GGT 21 U/L, Total bilirubin 0.4 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.8 g/dL, Total protein 7.4 g/dL","output":"Interpretation: Isolated ALP elevation.\nClinical significance: Likely bone turnover.\nFuture risks: Vitamin D deficiency.\nLifestyle & follow-up: Test vitamin D; consider supplementation."}
{"instruction":"Interpret liver function profile","input":"ALT 120 U/L, AST 115 U/L, ALP 150 U/L, GGT 200 U/L, Total bilirubin 1.0 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 3.5 g/dL, Total protein 6.7 g/dL","output":"Interpretation: Hepatic inflammation with cholestasis.\nClinical significance: NAFLD, alcohol-related injury or medications.\nFuture risks: Progressive fibrosis.\nLifestyle & follow-up: Avoid alcohol, manage weight, and monitor lipids."}
{"instruction":"Interpret liver function profile","input":"ALT 29 U/L, AST 24 U/L, ALP 134 U/L, GGT 26 U/L, Total bilirubin 0.7 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.6 g/dL, Total protein 7.3 g/dL","output":"Interpretation: ALP elevation suggests extrahepatic source.\nClinical significance: Bone-related abnormality likely.\nFuture risks: Osteopenia/osteoporosis.\nLifestyle & follow-up: Evaluate vitamin D and calcium intake."}
{"instruction":"Interpret liver function profile","input":"ALT 411 U/L, AST 458 U/L, ALP 175 U/L, GGT 230 U/L, Total bilirubin 3.4 mg/dL, Direct bilirubin 1.2 mg/dL, Albumin 2.9 g/dL, Total protein 6.0 g/dL","output":"Interpretation: Severe acute liver injury.\nClinical significance: Likely acute viral hepatitis or toxic damage.\nFuture risks: Hepatic encephalopathy.\nLifestyle & follow-up: Emergency care required."}
{"instruction":"Interpret liver function profile","input":"ALT 95 U/L, AST 88 U/L, ALP 110 U/L, GGT 155 U/L, Total bilirubin 1.3 mg/dL, Direct bilirubin 0.4 mg/dL, Albumin 3.7 g/dL, Total protein 6.5 g/dL","output":"Interpretation: Mild hepatocellular injury.\nClinical significance: Consistent with early fatty liver.\nFuture risks: Metabolic syndrome.\nLifestyle & follow-up: Weight reduction and physical activity recommended."}
{"instruction":"Interpret liver function profile","input":"ALT 23 U/L, AST 22 U/L, ALP 260 U/L, GGT 19 U/L, Total bilirubin 0.6 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.5 g/dL, Total protein 7.3 g/dL","output":"Interpretation: Isolated ALP elevation.\nClinical significance: Likely bone-related.\nFuture risks: Vitamin D deficiency.\nLifestyle & follow-up: Check calcium, phosphate, vitamin D."}
{"instruction":"Interpret liver function profile","input":"ALT 66 U/L, AST 58 U/L, ALP 138 U/L, GGT 180 U/L, Total bilirubin 1.0 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 3.8 g/dL, Total protein 6.8 g/dL","output":"Interpretation: Mixed enzyme elevation.\nClinical significance: Suggestive of alcohol or fatty liver.\nFuture risks: Liver fibrosis.\nLifestyle & follow-up: Avoid alcohol; repeat test in 6–8 weeks."}
{"instruction":"Interpret liver function profile","input":"ALT 345 U/L, AST 320 U/L, ALP 160 U/L, GGT 210 U/L, Total bilirubin 2.6 mg/dL, Direct bilirubin 0.9 mg/dL, Albumin 3.0 g/dL, Total protein 6.2 g/dL","output":"Interpretation: Severe liver injury.\nClinical significance: Strongly suggests acute hepatitis.\nFuture risks: Acute liver failure.\nLifestyle & follow-up: Urgent hepatology referral."}
{"instruction":"Interpret liver function profile","input":"ALT 15 U/L, AST 18 U/L, ALP 92 U/L, GGT 20 U/L, Total bilirubin 0.4 mg/dL, Direct bilirubin 0.0 mg/dL, Albumin 4.9 g/dL, Total protein 7.0 g/dL","output":"Interpretation: Normal liver function profile.\nClinical significance: No abnormalities detected.\nFuture risks: None.\nLifestyle & follow-up: Routine monitoring yearly."}
{"instruction":"Interpret liver function profile","input":"ALT 140 U/L, AST 120 U/L, ALP 136 U/L, GGT 150 U/L, Total bilirubin 0.9 mg/dL, Direct bilirubin 0.3 mg/dL, Albumin 3.6 g/dL, Total protein 6.6 g/dL","output":"Interpretation: Mild to moderate mixed elevation.\nClinical significance: NAFLD likely.\nFuture risks: Steatohepatitis.\nLifestyle & follow-up: Weight loss, less sugar, more fiber."}
{"instruction":"Interpret liver function profile","input":"ALT 210 U/L, AST 190 U/L, ALP 145 U/L, GGT 180 U/L, Total bilirubin 1.7 mg/dL, Direct bilirubin 0.6 mg/dL, Albumin 3.4 g/dL, Total protein 6.3 g/dL","output":"Interpretation: Hepatic inflammation.\nClinical significance: Possible viral hepatitis or autoimmune disease.\nFuture risks: Hepatic scarring.\nLifestyle & follow-up: Viral markers, autoimmune profile."}
{"instruction":"Interpret liver function profile","input":"ALT 60 U/L, AST 52 U/L, ALP 128 U/L, GGT 130 U/L, Total bilirubin 0.8 mg/dL, Direct bilirubin 0.2 mg/dL, Albumin 4.0 g/dL, Total protein 6.7 g/dL","output":"Interpretation: Mild liver enzyme increase.\nClinical significance: Possibly fatty liver.\nFuture risks: Metabolic complications.\nLifestyle & follow-up: Reduce body fat, improve diet."}
{"instruction":"Interpret liver function profile","input":"ALT 19 U/L, AST 22 U/L, ALP 175 U/L, GGT 24 U/L, Total bilirubin 0.7 mg/dL, Direct bilirubin 0.1 mg/dL, Albumin 4.5 g/dL, Total protein 7.1 g/dL","output":"Interpretation: ALP elevated; non-liver origin suspected.\nClinical significance: Could be bone turnover or vitamin D deficiency.\nFuture risks: Weak bones.\nLifestyle & follow-up: Vitamin D supplementation advised."}

